BRIEF-Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement

Reuters07-22

July 22 (Reuters) - Hepion Pharmaceuticals Inc :

* PHARMA TWO B ANNOUNCES PLANS TO GO PUBLIC VIA MERGER WITH HEPION PHARMACEUTICALS, INC. AND CONCURRENT $11.5 MILLION PRIVATE PLACEMENT

* HEPION PHARMACEUTICALS INC: CURRENT PHARMA TWO B EQUITY-HOLDERS WILL OWN ABOUT 85% OF COMBINED COMPANY

* HEPION PHARMACEUTICALS : CURRENT HEPION EQUITY-HOLDERS WILL OWN ABOUT 15% OF COMBINED COMPANY

* HEPION PHARMACEUTICALS- ENTERED PURCHASE DEAL WITH INSTITUTIONAL INVESTORS FOR SALE OF $2.9 MILLION SENIOR UNSECURED NOTE

* HEPION PHARMACEUTICALS INC: PROPOSED DEAL FOR $58.5 MILLION

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2453764366?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-22 20:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2453764366","market":"us","top_or_hot":-1,"title":"BRIEF-Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement","media":"Reuters","content":"<html><body><p>July 22 (Reuters) - Hepion Pharmaceuticals Inc   :</p><p>   * PHARMA TWO B ANNOUNCES PLANS TO GO PUBLIC VIA MERGER WITH HEPION PHARMACEUTICALS, INC. AND CONCURRENT $11.5 MILLION PRIVATE PLACEMENT</p><p>   * HEPION PHARMACEUTICALS INC: CURRENT PHARMA TWO B EQUITY-HOLDERS WILL OWN ABOUT 85% OF COMBINED COMPANY</p><p>   * HEPION PHARMACEUTICALS : CURRENT HEPION EQUITY-HOLDERS WILL OWN ABOUT 15% OF COMBINED COMPANY</p><p>   * HEPION PHARMACEUTICALS- ENTERED PURCHASE DEAL WITH INSTITUTIONAL INVESTORS FOR SALE OF $2.9 MILLION <a href=\"https://laohu8.com/S/SNR.UK\">SENIOR</a> UNSECURED NOTE</p><p>   * HEPION PHARMACEUTICALS INC: PROPOSED DEAL FOR $58.5 MILLION</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-22 20:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>July 22 (Reuters) - Hepion Pharmaceuticals Inc   :   * PHARMA TWO B ANNOUNCES PLANS TO GO PUBLIC VIA MERGER WITH HEPION PHARMACEUTICALS, INC. AND CONCURRENT $11.5 MILLION PRIVATE PLACEMENT   * HEPION ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2453764366","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2453764366","pubTimestamp":1721650869,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"July 22  - Hepion Pharmaceuticals Inc   :   * PHARMA TWO B ANNOUNCES PLANS TO GO PUBLIC VIA MERGER WITH HEPION PHARMACEUTICALS, INC. AND CONCURRENT $11.5 MILLION PRIVATE PLACEMENT   * HEPION PHARMACEUTICALS INC: CURRENT PHARMA TWO B EQUITY-HOLDERS WILL OWN ABOUT 85% OF COMBINED COMPANY   * HEPION PHARMACEUTICALS : CURRENT HEPION EQUITY-HOLDERS WILL OWN ABOUT 15% OF COMBINED COMPANY   * HEPION PHARMACEUTICALS- ENTERED PURCHASE DEAL WITH INSTITUTIONAL INVESTORS FOR SALE OF $2.9 MILLION SENIOR UNSECURED NOTE   * HEPION PHARMACEUTICALS INC: PROPOSED DEAL FOR $58.5 MILLIONSource text for Eikon:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","HEPA":"Hepion Pharmaceuticals, Inc."},"translate_title":"简介-Pharma Two B计划通过与Hepion Pharmaceuticals合并上市，同时私募1150万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HEPA":0.9},"content_text":"July 22 (Reuters) - Hepion Pharmaceuticals Inc   :   * PHARMA TWO B ANNOUNCES PLANS TO GO PUBLIC VIA MERGER WITH HEPION PHARMACEUTICALS, INC. AND CONCURRENT $11.5 MILLION PRIVATE PLACEMENT   * HEPION PHARMACEUTICALS INC: CURRENT PHARMA TWO B EQUITY-HOLDERS WILL OWN ABOUT 85% OF COMBINED COMPANY   * HEPION PHARMACEUTICALS : CURRENT HEPION EQUITY-HOLDERS WILL OWN ABOUT 15% OF COMBINED COMPANY   * HEPION PHARMACEUTICALS- ENTERED PURCHASE DEAL WITH INSTITUTIONAL INVESTORS FOR SALE OF $2.9 MILLION SENIOR UNSECURED NOTE   * HEPION PHARMACEUTICALS INC: PROPOSED DEAL FOR $58.5 MILLIONSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2453764366"}